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Human Enhancement and Experimental Research in
the Military
EFTHIMIOS PARASIDIS
For over a century the US. military has conducted and sponsored
cutting-edge medical and technological research. While such projects have
often resulted in transformative innovations, in a number of instances,
researchers have deliberately violated legal requirements and/or ethical
norms governing research with human subjects. This Article explores these
matters by discussing the history of misfeasance in military research and
examining contemporary military endeavors that aim to exploit biomedical
advancements.
ARTICLE CONTENTS
I. IN TR O D U CTIO N ................................................................................. 1119
II. A HISTORY OF UNCONSCIONABLE RESEARCH ........................ 1120
III. PRESERVING AND ENHANCING THE FIGHTING FORCE ........ 1124
A. INVESTIGATIONAL AND OFF-LABEL
USE OF M EDICAL PRODUCTS ........................................................ 1124
B. PHYSICAL AND COGNITIVE ENHANCEMENT
OF SERVICE M EM BERS .................................................................. 1129
IV . CO N CLU SIO N ................................................................................... 1131
Human Enhancement and Experimental Research in
the Military
EFTHIMIOS PARASIDIS*
I. INTRODUCTION
This Article examines experimental research in the U.S. military
through the eyes of the human subject. It explores the egregious legal and
ethical violations committed by military researchers in the mid-to-late
twentieth century and evaluates investigational studies that have shadowed
military medicine for the past two decades. At a time when the U.S.
military is actively pursuing transformative biomedical and technological
innovations, analyzing the history of misfeasance in military research
informs contemporary discussion as to the extent to which legal and
regulatory reforms are desirable.
Modem military medicine has evolved from its traditional role of
"preserving the fighting force,"' to enhancing it through application of
novel biotechnologies' Current research sponsored by the U.S.
Department of Defense ("DoD") and the Defense Advanced Research
Projects Agency ("DARPA") includes drugs that can keep soldiers awake
for seventy-two hours or more, a nutraceutical that fulfills a soldier's
dietary needs for up to five days, and sophisticated brain-to-computer
interfaces that endeavor to permit human-to-human and human-to-
" Efthimios Parasidis, Assistant Professor of Law, Center for Health Law Studies, Saint Louis
University School of Law. This Article is based on my presentation at the Connecticut Law Review
Symposium titled, Healthcare Reform in the United States: Legal Implications and Policy
Considerations, where I served on a panel that addressed current health issues facing veterans and
service members. I thank Symposium Editors Marco Allocca and Stephanie Bartone for inviting me to
the symposium and hosting a well-organized and enlightening event. Special thanks to Editor-in-Chief
Abigail Langer, Managing Editor Paul Costa, and the staff of the Connecticut Law Review for
outstanding editorial assistance. This project benefited from discussions with Symposium panelists and
participants. Monica Eppinger, Chad Flanders, Jeff Redding, and Magdalen Sarrinikolaou provided
insightful comments on early drafts of this work.
1 Mike Mitka, US Military Medicine Moves to Meet Current Challenge, 286 JAMA 2532, 2532-
33 (2001) (describing the evolution in battlefield medical priorities).
2 See, e.g., JONATHAN D. MORENO, MIND WARS: BRAIN RESEARCH AND NATIONAL DEFENSE 11-
13 (2006) (cataloguing neuroscience innovations by DARPA that aim to improve the military's fighting
capabilities); Catherine L. Annas & George J. Annas, Enhancing the Fighting Force: Medical
Research on American Soldiers, 25 J. CONTEMP. HEALTH L. & POL'Y 283, 287 (2009) (noting the shift
in medical priorities in the American military).
computer communication via thought alone.3
In addition to increased health risks associated with enhancement
techniques, a number of challenging legal and bioethical issues have been
insufficiently explored. Should enhancements be a mandatory aspect of
military service? Who determines the parameters for an acceptable risk-
benefit profile? What remedies should be available for service members
who experience adverse health effects? Adequately addressing these
concerns, particularly in the context of military hierarchy and demography,
provides a socio-medical framework that facilitates sensible harmonization
of national security interests with fundamental notions of human dignity
and patient autonomy.
II. A HISTORY OF UNCONSCIONABLE RESEARCH
The atrocities committed by German military researchers during World
War II challenged the international community to directly address
safeguards governing experimental research on human subjects. While the
U.S. military played an integral role in the prosecution of the German
researchers and the drafting of the Nuremburg Code, the U.S. government
failed to publicly disclose its involvement in unethical, if not illegal,
experimental research on American civilians and service members.4 Three
examples include studies related to mustard gas, nuclear weapons, and
psychotropic drugs.
The mustard gas experiments involved approximately 60,000
American soldiers in "race-based human experimentation" that sought to
determine whether race or skin complexion influences one's susceptibility
to injuries from mustard gas. 5 Researchers created "man-break" tests
3See MORENO, supra note 2, at 51 (discussing innovations in the "'human-computer'
combination"); Annas & Annas, supra note 2, at 285-86 (describing projects that seek technologies
which would make it possible for soldiers to perform for several days without sleep); Hannah Hoag,
Remote Control, 423 NATURE 796, 796 (2003) (discussing DARPA's quest to develop technologies to
interface the brain and computers); Noah Shachtman, Darpa Offers No Food for Thought, WIRED
(Feb. 17, 2004), http://www.wired.com/print/medtech/health/news/2004/02/62297 (describing
DARPA's "Metabolic Dominance" project).
4 See David P. Rail et al., Preface to VETERANS AT RISK: THE HEALTH EFFECTS OF MUSTARD
GAS AND LEWISITE v-vii (Constance M. Pechura & David P. Rail eds., 1993) (discussing U.S. medical
research during World War II and failures to disclose the extent of the program) [hereinafter IOM
Report]. In the 1940s and 1950s, articles in the popular press "suggest[ed] some tension between the
[American] words at Nuremberg and the practices in America." FINAL REPORT OF THE ADVISORY
COMMITTEE ON HuMAN RADIATION EXPERIMENTS 87 (Oxford Univ. Press 1996) [hereinafter Human
Radiation Experiments Report].
5 IOM Report, supra note 4, at v; Susan L. Smith, Mustard Gas and American Race-Based
Human Experimentation in World War If, 36 J.L. MED. & ETHICS 517, 517 (2008). Researchers
suspected that non-whites would have a different response than whites. Id. at 518. For example,
researchers at Cornell University Medical Center believed that non-whites had thicker skin which may
make them less sensitive to mustard gas when compared to whites. Marion B. Sulzberger et al., Skin
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whereby service members were locked in gas chambers that were
inundated with mustard gas until the point that the men became
incapacitated.6 During the experiments, some soldiers were exposed to gas
levels that were equivalent to those reported on World War I battlefields.'
The "man-break" tests caused severe injuries to the service members.
Soldiers experienced "immediate and severe eye injuries" and "enormous,
grotesque blisters and oozing sores" on their "face, hands, underarms,
buttocks, and genitals." 8 Exposure to mustard gas also caused blindness,
intense vomiting, internal and external bleeding, and damage to the lungs
and respiratory system.9 Many soldiers suffered long-term health effects
that included cancer, asthma, and psychological disorders.'0
For decades, the U.S. government refused to acknowledge the
existence of the studies or provide injured service members with
compensation or long-term health care. It was not until 1991-nearly five
decades after the first studies began-that the government officially
admitted to the use of soldiers in experimental research. The government
also admitted that it did not fully disclose safety risks or obtain informed
consent from the research participants, and that the service members may
have suffered adverse health effects as a result of their participation in the
studies."
Contemporaneous with the mustard gas experiments, the U.S. military
conducted radiation experiments on American soldiers and civilians.'" In
addition to testing the destructive capabilities of nuclear weapons, military
researchers examined the effects of nuclear warfare on humans, animals,
and the environment.1 3  As early as 1942, the military understood that
exposure to radiation was likely to be quite dangerous, since "the
deleterious effects of radiation could not be seen or felt and the results of
over-exposure might not become apparent for long periods after such
exposure."' 4
Sensitization to Vesicant Agents of Chemical Warfare, 8 J. INVESTIGATIVE DERMATOLOGY 365, 365
n.1, 372 (1947).
6 Smith, supra note 5, at 518. Other experiments had soldiers stand in a field, wearing various
levels of protective clothing, as low-flying airplanes sprayed the men with mustard gas. Id.
7 IOM Report, supra note 4, at vii.
8 Smith, supra note 5, at 518.
91d.
1O Id.
11 IOM Report, supra note 4, at v-vi. In turn, the government offered compensation and medical
treatment for research-related injuries. Expanded Benefits for Vets Hurt by Gas Tests, CHI. TRIB., Jan.
7, 1993, at NI4.
12 Human Radiation Experiments Report, supra note 4, at xxx, 14 (noting that the experiments
were conducted from 1944 to 1974).
13 Leonard W. Schroeter, Human Experimentation, the Hanford Nuclear Site, and Judgment at
Nuremberg, 31 GONZ. L. REV. 147, 213 (1996).
14 Human Radiation Experiments Report, supra note 4, at 6 (citation omitted).
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After years of detonating atomic weapons in the South Pacific, the
military began open air testing of nuclear weapons on American soil in the
1950s. 15 Thousands of soldiers were placed, without protective clothing, in
the immediate vicinity of atomic detonations. The military did not inform
the soldiers of potential health risks or seek to obtain informed consent
prior to participation in the trials.
While the military publicly denied any potential harm to humans,
plants, or animals, internal documents indicate that government officials
had determined that there existed a causal relationship between radiation
exposure and serious adverse health effects. 16  Despite the health and
environmental hazards, the Commissioner of the U.S. Atomic Energy
Commission privately asserted that "[w]e must not let anything interfere
with this series of tests-nothing."'17 It was later revealed that radiation
exposure at the test sites was comparable to that of Hiroshima and
Nagasaki.' 8
Coupled with the open-air nuclear tests, the military funded studies at a
number of well-respected American universities, including the University
of Chicago and the University of California, whereby researchers injected
unsuspecting civilians with radioactive elements that included plutonium,
uranium, and polonium.' 9 This work continued through the 1970s, with
researchers targeting the elderly, patients in mental institutions, prisoners,
and others "who did not have full faculties for informed consent."20 A
congressional investigation later found that "[n]o evidence was elicited that
informed consent was granted in any of the cases," and that "[t]he
government covered up the nature of the experiments and deceived the
,,2 1families of deceased victims ....
In the 1990s, the government acknowledged that hundreds of
thousands of American service members had been involved in at least 1400
radiation projects over a thirty-year period during and after World War II.
These figures do not include exposure suffered by American civilians in
connection with hundreds of "intentional radiation releases," where
15 See Howard Ball, Downwindfrom the Bomb, N.Y. TIMES, Feb. 9, 1986, (§ 6), at 33 (recounting
the history of American nuclear testing beginning in the 1950s). Approximately one hundred atomic
detonations occurred on U.S. soil during the 1950s. Id.
16 id.
17 id.
18 See Schroeter, supra note 13, at 213.
19 See Human Radiation Experiments Report, supra note 4, at 160-61.
20 See Schroeter, supra note 13, at 157-58. For example, the Massachusetts Institute of
Technology fed elderly patients radium and thorium, two radioactive elements that could have no
benefit to the test subjects. Id. at 158. Over a period of eight years, the University of Washington
Medical School x-rayed the testes of prisoners to examine the effects of ionizing radiation on human
fertility and testicular function. Id.
21 Id. at 157-58.
22 Schroeter, supra note 13, at 151.
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researchers deliberately emitted radioactive substances into densely
populated cities and other locations to test human response and
environmental contamination. 23 Although the government was aware that
the radiation releases were likely to contaminate food and water supplies,
many of the releases "took place with no public awareness or
understanding., 24  Within ten years after the commencement of the
detonations in America, childhood leukemia deaths and diagnoses, as well
as adult cancer deaths and diagnoses, were exponentially higher in several
detonation regions.25
Along with the mustard gas and radiation experiments, the U.S.
military engaged in decades of classified research, beginning in the 1940s
and continuing through the 1970s, to ascertain whether psychotropic drugs
could be used as chemical weapons or interrogation-facilitating agents.26
The products under investigation included lysergic acid diethylamide
(LSD), synthetic mescaline, synthetic marijuana, and over a dozen other
drugs. During the early stages of the research, the U.S. military recruited
Nazi scientists who had studied and participated in torture and
brainwashing.27 Several of the Germans had been recently identified as
war criminals, and the U.S. falsified documents to conceal their true
identities. 28 The military later justified its actions by arguing that national
security interests far outweighed any ethical concerns.29
The psychotropic drugs were given to service members and civilians
without their knowledge or consent. 3 Studies were conducted in military
facilities and university medical centers, and many human subjects
experienced serious adverse side effects.3' Internally, the military justified
the secret testing on "'unwitting, nonvolunteer' Americans" by arguing
that national security interests permit "a more tolerant interpretation of
moral-ethical values, but not legal limits. 32 The military went on to argue
23 Human Radiation Experiments Report, supra note 4, at 318-22.
24 Id. at 318.
25 Ball, supra note 15, at 33.
26 See Paul J. Amoroso & Lynn L. Wenger, The Human Volunteer in Military Biomedical
Research, in 2 MIL. MED. ETHICS 563, 570 (Thomas E. Beam & Linette R. Sparacino eds., 2003)
(discussing the military's use of LSD on unknowing Americans); see also David H. Price, Buying a
Piece of Anthropology, 23 ANTHROPOLOGY TODAY 8, 8-9 (2007) (discussing the CIA's programs to
study mind control, brainwashing, interrogation, and torture).
27 See John Gimbel, German Scientists, United States Denazification Policy, and the 'Paperclip
Conspiracy,' 12 INT'L HISTORY REV. 441, 441-42 (1990); Peter A. Masley, The Paperclip File;
America's Secret Agenda to Import Nazi Intelligence, WASH. POST, Aug. 16, 1991, at D3.
28 See Gimbel, supra note 27, at 441-42.
29 Id. at 441-42; Andrew Walker, Project Paperclip: Dark Side of the Moon, BBC NEWS (Nov.
21, 2005), http://news.bbc.co.uk/2/hi/uk-news/magazine/4443934.stm.
30 Price, supra note 26, at 9.
"' Id. at 9-11.
32 United States v. Stanley, 483 U.S. 669, 686, 688 (1987) (Brennan, J., concurring in part and
dissenting in part) (citations omitted).
2012]
that legal liability could be avoided by covering up the experiments.33
III. PRESERVING AND ENHANCING THE FIGHTING FORCE
There is nothing to suggest that the U.S. military is currently
supporting research that utilizes methods similar to those employed during
the mustard gas, radiation, or psychotropic drug experiments. However,
recent controversies have highlighted the military's efforts to mandate use
of medical products for off-label or investigational purposes, and its
emphasis on developing biotechnologies that seek to facilitate the
cognitive and physical enhancement of service members.34 This Part will
focus on these two areas of research.
A. Investigational and Off-Label Use of Medical Products
Since at least the 1990s, the U.S. military has required service
members to subject themselves to both investigational and off-label use of
medical products.35  Both off-label and investigational use involve
utilization of a medical product for an indication that has not earned FDA
approval.36 While each is properly characterized as experimental research
because the FDA has not found that the underlying product is safe and
effective for the stated use, there is an important distinction between the
two categories. For products that are used off-label, the FDA has
determined that the product is safe and effective for at least one
indication.37 Investigational medical products, on the other hand, have not
been approved for any indication.38
Nonconsensual use of off-label or investigational medical products
raises a number of serious concerns. While physicians may prescribe
drugs for off-label indications or investigational purposes, the decision to
do so must be based on an evaluation of a patient's particular health
13 Id. at 689.
34 See Annas & Annas, supra note 2, at 301-04 (discussing how, in the war on terror, physicians
have participated in prisoner interrogations and prisoner hunger strikes, and the military has prescribed
psychotropic medications, particularly selective serotonin-reuptake inhibitors, to soldiers in order to
keep them in combat areas or to have them serve another tour of duty).
35 See Stuart L. Nightingale et al., Emergency Use Authorization (EUA) to Enable Use of Needed
Products in Civilian and Military Emergencies, United States, 13 EMERGING INFECTIOUS DISEASES
1046, 1047 (2007) (stating that in preparation for the Persian Gulf War, the U.S. military administered
unapproved drugs to service members without informed consent).
3 6 See generally U.S. FOOD AND DRUG ADMIN., "OFF-LABEL" AND INVESTIGATIONAL USE OF
MARKETED DRUGS, BIOLOGICS, AND MEDICAL DEVICES (1998), available at
http://www.fda.gov/Regulatorylnformation/Guidances/ucm126486.htm.
37 1d; Randall S. Stafford, Regulating Off-Label Drug Use-Rethinking the Role of the FDA, 358
NEW ENG. J. MED. 1427, 1427 (2008).
38 See Susan Okie, Access Before Approval-A Right to Take Experimental Drugs?, 355 NEW
ENG. J. MED. 437, 439 (2006) (noting that only eleven percent of drugs that enter clinical trials are
ultimately approved by the FDA).
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condition and risk factors, and should only occur where medical data
reflect meaningful evidence that the potential benefits are likely to
outweigh the known or expected risks and the patient provides informed
consent to the treatment. In a number of instances, the military has made
off-label and investigational use of medical products compulsory for
service members as a whole, and has not sought to obtain informed consent
or provide adequate risk disclosures to individual soldiers. The discussion
below explores four recent examples-pyridostigmine bromide ("PB"), the
botulinum toxoid ("BT") vaccine, the anthrax vaccine, and selective
serotonin reuptake inhibitors ("SSRIs").
After petitioning the FDA to establish a new rule that waives informed
consent requirements for investigational use of medical products in times
of existing or anticipated combat activities, the DoD sought and obtained
permission from the FDA to use PB and the BT vaccine pursuant to the
new regulation. 39 Fearing use of chemical weapons during the Gulf War,
the military decided to administer PB and the BT vaccine to all soldiers.40
At the time, the FDA was evaluating the safety and efficacy of both
products as pretreatments for chemical warfare.4'
In its informed consent waiver request to the FDA, the DoD argued
that it would not be feasible to obtain informed consent because a soldier's
"personal preference" does not supersede the military's view that the drug
and vaccine would contribute to the "safety of other personnel in a
soldier's unit and the accomplishment of the combat mission. '42 The DoD
also argued that "obtaining informed consent in the heat of imminent or
ongoing combat would not be practicable. '' 3
The FDA granted the DoD's requests, but the decision was not without
controversy. The DoD claims that it trusted that the FDA had granted
permission to use the investigational drug without informed consent
because the FDA believed that the drug was deemed to be safe.44 The
FDA, on the other hand, claims that it granted the waiver because it
believed that the DoD determined that military necessity required an
45informed consent waiver.
Regardless of the reason why the FDA granted the waiver, as a
condition of the FDA's permission to use the investigational medical
products without informed consent, the DoD agreed to: (1) provide
information on PB to all service members; (2) collect, review, and make
39 Doe v. Sullivan, 938 F.2d 1370, 1372 n.1, 1374 (D.C. Cir. 1991).40 Id. at 1371-72, 1372 n.l.
41 Id. at 1372 n.I.
42 Id. at 1373.
43 Id.
4Annas & Annas, supra note 2, at 301-02.
41 Id. at 302.
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reports of adverse events related to PB; (3) label PB as an investigational
product that was solely for "military use and evaluation;" (4) ensure that
each dose of the BT vaccine was recorded in each service member's
medical record; and (5) maintain adequate records related to the receipt,
shipment, and disposition of the BT vaccine.46 The DoD failed to comply
with each of these requirements.47
Following use of PB and the BT vaccine during the Gulf War, veterans
began suffering from serious health problems that include cognitive
difficulties, chronic headaches, widespread pain, skin rashes, respiratory
and gastrointestinal problems, and other chronic abnormalities.48 Gulf War
veterans have been diagnosed with amyotrophic lateral sclerosis ("ALS")
at a much higher rate than that of the general population or veteran
populations from other wars.49 Children of Gulf War veterans are also
born with birth defects at an alarming rate.5° Commonly referred to as
Gulf War illness, these health problems affect over 175,000 Gulf War
veterans, which amounts to more than twenty-five percent of the fighting
force during the war.51 PB is included in the list of factors that are most
likely to be a contributing factor to Gulf War illness.52
The military's off-label use of vaccines continued after the Gulf War.
In 1998, the DoD implemented the Anthrax Vaccine Immunization
Program ("AVIP"), which requires the anthrax vaccine for all service
53members who are deemed by DoD to be at risk for anthrax exposure.
Although the vaccine had earned FDA approval to protect against
46 Revocation of 1990 Interim Final Rule, 64 Fed. Reg. 54180, 54184 (Oct. 5, 1999) (codified at
21 C.F.R. pts. 50 & 320 (2010)) ("There was a failure to meet the conditions set by the Commissioner
for granting a waiver from the informed consent requirements under the 1990 interim rule ...47 Id.
48 
RESEARCH ADVISORY COMM. ON GULF WAR VETERANS' ILLNESSES, GULF WAR ILLNESS AND
THE HEALTH OF GULF WAR VETERANS 1 (2008) [hereinafter Gulf War Illness Report].49 Id. at 6 (reporting that Gulf War veterans developed ALS at twice the rate of non-deployed
veterans of the same era).
5
o d.
5 Id. at 4.52 1d. at 7-10; see also Justice Delayed: Acknowledging the Reality of Gulf War Illness, 372
LANCET 1856, 1856 (2008) ("Gulf War veterans have long complained of cognitive problems,
headaches, fatigue and pain, and chronic digestive, respiratory, and skin disorders. . . . The
constellation of symptoms has now been attributed to two agents: pesticides and pyridostigmine
bromide .... ). In 2003, more than two decades after use of PB by the U.S. military, the drug was
approved for use in combat through the Bioterrorism Act's animal-efficacy standard. See William J.
FitzPatrick & Lee L. Zwanziger, Defending Against Biochemical Warfare: Ethical Issues Involving the
Coercive Use of Investigational Drugs and Biologics in the Military, 3 J. PHIL., SCI. & L. 1, 2 (2003)
("This 'animal efficacy rule' allows for the possibility of moving some hitherto 'investigational'
compounds into the category of approved drugs or biologics, which would also obviate the need in
such cases for a special Presidential waiver of the consent requirement for the administration of such
compounds . . . . This change in status has in fact just occurred in the case of pyridostigmine
bromide.., which was approved for combat use on 5 February 2003 ... .
53 Rempfer v. Sharfstein, 583 F.3d 860, 863 (D.C. Cir. 2009).
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cutaneous anthrax, the military sought to use the vaccine as a pretreatment
for inhalation anthrax.54
In 2003, six service members filed a lawsuit seeking to enjoin the
military from continuing AVIP because the military did not obtain
informed consent prior to inoculations, nor did the DoD obtain a waiver for
the informed consent requirements.5" A federal district court issued a
preliminary injunction that halted AVIP.56 Days later, the FDA approved
the anthrax vaccine "independent of the route of exposure," which
captured the indication of inhalation anthrax.57 The court then vacated the
FDA's decision on procedural grounds because the agency did not follow
its requirement to certify that the vaccine was safe and effective against
inhalation anthrax.58 In essence, the court found it impossible for the FDA
to have adequately evaluated the products, pursuant to the statutory
requirements, in such a short time period.
Congress stepped in to aid the DoD by enacting the Project BioShield
Act of 2004,5 9 which granted the FDA the ability to permit off-label or
investigational use of medical products during a declared emergency.60 In
turn, the FDA used its newfound power to grant the DoD the ability to
continue using the anthrax vaccine. 6' During the time that the DoD was
permitted to continue with AVIP pursuant to the emergency order, the
FDA approved the vaccine regardless of the route of exposure.62 Although
service members once again challenged the FDA's decision, the Court of
Appeals for the D.C. Circuit dismissed the action because it found that the
FDA had not acted arbitrarily or capriciously in approving the new
indication during its second review.63 Since March 1998, over 2,700,000
service members have received the anthrax vaccine. 64  For a number of
14 Id. at 863-64.
55 Id.
Id. at 864.
"Id. at 863-64.
Id. at 864.
'9 21 U.S.C. § 360bbb-3 (2006).
6 See Nightingale et al., supra note 35, at 1046 (describing the Project BioShield Act's
establishment of the comprehensive Emergency Use Authorization ("EUA") program, which permits
the FDA to "approve the emergency use of drugs, devices, and medical products ... that were not
previously approved, cleared, or licensed by FDA . . . or the off-label use of approved products in
certain well-defined emergency situations").
61 Id. at 1050.
62 See Rempfer, 583 F.3d at 864 (stating that, after issuing a proposed order for comment and
reviewing those comments, the FDA issued a new final order on December 19, 2005 that classified the
anthrax vaccine as "safe and effective in the prevention of anthrax regardless of the route of
exposure").
63 Id. at 867-68.
64 See Why Get Vaccinated, BIoTHRAx, http://www.biothrax.com/whatisbiothrax/
whygetvaccinated.aspx, (last visited Feb. 16, 2012) (stating that more than 10 million doses of
BioThrax Anthrax Vaccine have been administered to 2.7 million people); see also Anthrax Vaccine
2012)
service members, however, the administration of the vaccine is not
reflected in the official medical records maintained by the military.65
Today, some of the most pressing medical issues facing service
members include traumatic brain injury ("TBI"), post-traumatic stress
66 o nesdisorder ("PTSD"), and other mental health issues. A decade of intense
fighting in Afghanistan and Iraq has resulted in a "substantial mental
health burden for war veterans and their families."6 7 Blast-related TBI has
been labeled the signature injury of the wars, and countless soldiers have
reported post-concussive symptoms. 68  Veterans of these wars have
required mental health treatment for serious mental disorders much more
than veterans of previous wars, and suicide rates for enlisted service
members and veterans are at an all-time high.69
Increasingly, treatments for depression, TBI, PTSD, and anxiety
disorders utilize newer psychotropic medications, particularly selective
serotonin-reuptake inhibitors.70 Military psychiatrists have recommended
that physicians in war zones have SSRIs "in large quantities, to be used for
both depressive disorders and anxiety disorders."'', However, a number of
studies have questioned the safety and efficacy of SSRIs.72 Off-label use
of SSRIs is particularly troubling, with some studies finding no meaningful
clinical benefit and long-term adverse health effects.73 To the extent that
SSRIs are the standard of care for both on-label and off-label indications,
Immunization Program: Questions and Answers Overview, MIL. VACCINE (MILVAX) AGENCY,
http://www.anthrax.osd.mil/ (last visited March 30, 2012) (indicating that the military's AVIP program
has resulted in vaccination of 1.5 million DoD personnel).
65 See Anthrax Vaccine Immunization Program: Questions and Answers Anthrax and the Persian
Gulf War, MIL. VACCINE (MILVAX) AGENCY, http://www.anthrax.osd.mil/resource/qna/
qaAll.asp?clD=313 (last visited March 30, 2012) (acknowledging that more effort is still needed in
documenting vaccinations in service members's medical records).
66 See Charles W. Hoge, Interventions for War-Related Posttraumatic Stress Disorder, 306
JAMA 549, 549 (2011) (stating that about ten to twenty percent of U.S. infantry personnel have
developed post-deployment PTSD along with depression, substance abuse, and other health issues);
Charles W. Hoge et al., Mild Traumatic Brain Injury in US. Soldiers Returning from Iraq, 358 NEW
ENG. J. MED. 453,454 (2008).
67 Hoge, supra note 66, at 549.
68 Hoge et al., supra note 66, at 454.
69 Annas & Annas, supra note 2, at 304.
70 1 d. Examples of SSRIs include Prozac, Paxil, and Zolofi.
71 Id.
72 E.g., IRVING KIRSCH, THE EMPEROR'S NEW DRUGS: EXPLODING THE ANTIDEPRESSANT MYTH
75 (2010); Hoge, supra note 66, at 550; Marcia Angell, The Epidemic of Mental Illness: Why?, N.Y.
REV. BOOKS, June 23, 2011 [hereinafter Angell, Epidemic] (examining the risk-benefit profile for
SSRIs); Marcia Angell, The Illusions of Psychiatry, N.Y. REV. BOOKS, July 14, 2011 [hereinafter
Angell, Illusions].
73 See, e.g., KIRSCH, supra note 72, at 61; Hoge, supra note 66, at 550 (discussing specific side
effects such as weight gain and cardiac effects); Angell, Epidemic, supra note 72 (discussing industry's
role in suppressing clinical trials where the data reveal a product that is ineffective and unsafe); Angell,
Illusions, supra note 72 (identifying conflicts of interest in the pharmaceutical industry and off-label
promotion of SSRIs absent reliable evidence of safety and efficacy).
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and service members are not provided with accurate risk-benefit profiles,
such use may place service members at a heightened risk for both short-
term and long-term health problems.74
B. Physical and Cognitive Enhancement of Service Members
The fundamental goal of military training is to enhance service
members-to make them smarter, stronger, and more able fighters.
Increasingly, enhancement techniques have sought to leverage innovative
medical products and technologies. As the director of DARPA explains,
the agency's goal is to exploit "the life sciences to make the individual
warfighter stronger, more alert, more endurant, and better able to heal. 75
Such endeavors have raised a number of challenging questions. Is
there a valid distinction between "artificial" and "natural" enhancement?
Under what circumstances should enhancements that are under
development be administered to service members? Should medical
enhancements ever be a required aspect of service in the military?
Examining current enhancement projects helps frame these concerns.
DARPA's "Persistence in Combat" program aims to create soldiers
who are "unstoppable because pain, wounds, and bleeding are kept under
their control."7  This program includes research directed at developing a
vaccine that will block intense pain within seconds, use of
photobiomodulation to accelerate wound healing, and the creation of a
chemical cascade to stop bleeding within minutes.77 The agency's
Metabolic Dominance program seeks to create a "'nutraceutical,' a pill
with nutritional value that would vastly improve soldiers' endurance. 78
DARPA's vision is "to enable superior physical and physiological
performance by controlling energy metabolism on demand. An example is
continuous peak physical performance and cognitive function for 3 to 5
days, 24 hours per day, without the need for calories. 79
Coupled with these programs, "the security establishment's interest
and investment in neuroscience, neuropharmacology ... and related areas
[are] extensive and growing., 80 Under the Augmented Cognition program,
DARPA seeks to "develop the technologies needed to measure and track a
subject's cognitive state in real-time."'', Another goal is to create brain-to-
74 See Efthimios Parasidis, Patients Over Politics: Addressing Legislative Failure in the
Regulation of Medical Products, 2011 WIs. L. REv. 929, 987 (discussing factors that negatively impact
risk-benefit disclosures).
75 MORENO, supra note 2, at 11 (internal quotation marks omitted).
76 Annas & Annas, supra note 2, at 286 (internal quotation marks omitted).
77 Id.
79 MORENO, supra note 2, at 121.
79 id.
0 Id. at4.
1 Id. at 51.
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computer interfaces, whereby soldiers can communicate by thought
alone.82 This includes systems that can relay messages, such as images and
sounds, between human brains and machines, or even from human to
human.83  Service members can receive commands via electrodes
implanted in their brains, or be wired directly into the equipment they
control.8 4
Through implanted electrodes, DARPA is researching whether
neurostimulation can improve impaired cognitive performance and reduce
the effects of sleep deprivation on soldiers.8 5 This research dovetails with
two other DARPA endeavors, the Continuous Assisted Performance
program and the Applications of Biology to Defense Applications
program.16  The former is "investigating ways to prevent fatigue and
enable soldiers to stay awake, alert, and effective for up to seven days
straight without suffering any deleterious mental or physical effects and
without using any of the current generation of stimulants.,87  The latter
incorporates neuroscientific studies such as
[b]iological approaches for maintaining the warfighter's
performance, capabilities and medical survival in the face
of harsh battlefield conditions, biological approaches for
minimizing the after-effects of battle injuries, including
neurotrauma from penetrating and non-penetrating injuries
as well as faster recuperation from battlefield injury and
wounds[,] . . .[b]iomolecular motors and devices[,] ...
[m]icro/nano-scale technologies for non-invasive
assessment of health[,] . . . techniques for the decoding of
neural signals in real time[,] ... [n]ovel interfaces and
sensor designs for interacting with the central ...and
peripheral nervous systems[,] ...[and n]ew approaches
for understanding and predicting the behavior of
individuals and groups, especially those that elucidate the
neurobiological basis of behavior and decision making.88
Though DARPA-funded research is often cutting-edge and visionary,
about ninety percent of its projects fail.89 Those that succeed, however,
82 Hoag, supra note 3, at 798.
83 Id. at 796, 798.
'4 Id. at 796.
85 MORENO, supra note 2, at 127.
86 Id. at 11-13.
87 Id. at 11 (internal quotation marks omitted).
881d. at 12-13.
89 1d. at 12.
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often prove transformative for both military and civilian life.90 DARPA-
funded research has resulted in the creation of the Internet (initially called
the Darpanet), the computer mouse, the Stealth Fighter, and unmanned
aerial vehicles.9 As one DARPA official explains, "DARPA is about
trying to do those things, which are thought to be impossible, and finding
ways to make them happen.
92
IV. CONCLUSION
I have focused my discussion in this Article on military medicine and
research methods employed by the U.S. military in furtherance of its
mandate to protect national security interests. One need not question the
validity of the government's motivations to conduct experimental research
to understand that current and past research methods run contrary to
fundamental constitutional liberties and well-established research protocols
governing human subjects research.
Importantly, the unique relationship between a service member and his
or her commanding officer, and in turn, between the commanding officer
and his or her superiors, creates an environment with enormous potential
for abuse from a socio-medical context. Service members are legally
obligated to submit to biomedical treatments deemed necessary for the
good of the armed forces, even in instances where the treatments are purely
investigational or involve unapproved uses of FDA-approved medical
products. 93 Refusing "treatment" may be viewed as disobeying an order,
which can result in punitive measures that include a court-martial and
dishonorable discharge from the military. Coupled with the threat of
punitive measures, military hierarchy often compels soldiers to submit to
experimental treatment in instances where they otherwise may not have
provided consent.94
The risks to service members are compounded when one considers the
broad legal immunities that shield military researchers and the U.S.
government from civil claims. Under the Feres doctrine, service members
are precluded from raising tort claims against the government, government
employees, or third party contractors working in furtherance of
governmental research, if the underlying injury is sustained "in the course
90 See id. at 12-13 (providing examples of military research resulting in unprecedented civilian
life innovations).
9' Id. at 12.
92 Id. (internal quotation marks omitted) (quoting a DARPA official).
93 Doe v. Sullivan, 938 F.2d 1370, 1372-74 (D.C. Cir. 1991).
94 See IOM REPORT, supra note 4, at v-vii (explaining that the recruitment of "volunteer[]"
soldiers during World War I1 was accomplished through "lies and half-truths"); MORENO, supra note 2,
at 134; Annas & Annas, supra note 2, at 308 ("It seems likely that most soldiers will volunteer ... to
take whatever their superior officers recommend."); Smith, supra note 5, at 518.
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of activity incident to service." ' Service members are also precluded from
raising tort claims against the United States when the underlying injury
relates to a "discretionary function" of military policy. 96  The U.S.
Supreme Court has interpreted the Feres doctrine broadly to encompass
claims that arise from experimental research, even in instances where the
government covertly experimented upon soldiers and civilians, or
intentionally disregarded legal requirements and informed consent
protocols.
97
Understanding the history and dynamics of experimental research in
the military, along with the legal and regulatory framework that facilitates
such research, informs contemporary discussion of how best to harmonize
national security interests with fundamental notions of human dignity and
patient autonomy.9 While the goal of this Article has been to use human
enhancement and experimental research as paradigms to highlight the legal
and regulatory shortcomings of the current framework, proposals for
reform measures addressing these concerns will be the subject of future
scholarship.
99
9' Feres v. United States, 340 U.S. 135, 146 (1950) ("We conclude that the Government is not
liable under the Federal Tort Claims Act for injuries to servicemen where the injuries arise out of or are
in the course of activity incident to service. Without exception, the relationship of military personnel to
the Government has been governed exclusively by federal law. We do not think that Congress, in
drafting this Act, created a new cause of action dependent on local law for service-connected injuries or
death due to negligence. We cannot impute to Congress such a radical departure from established law
in the absence of express congressional command.").
96 Boyle v. United Tech. Corp., 487 U.S. 500, 511 (1988).
97 United States v. Stanley, 483 U.S. 669, 671,683-84 (1987).
98 Although commentators have highlighted medical and bioethical concerns affecting veterans
and service members, as discussion during the Symposium has revealed, the current debate surrounding
the constitutionality of the Patient Protection and Affordable Care Act has overshadowed meaningful
dialogue of a number of fundamental public health matters.
99 See Efthimios Parasidis, National Security, Military Research, and the Interests of Humanity,
73 OrIO ST. L.J. (forthcoming 2012).
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